ArticleWorld journal of gastrointestinal pharmacology and therapeutics2025

Risankizumab is effective following ustekinumab failure in Crohn's disease: A real-world study from a tertiary center.

Michael Colwill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.